vs
Side-by-side financial comparison of ASTRAZENECA PLC (AZN) and PDD Holdings Inc. (PDD). Click either name above to swap in a different company.
PDD Holdings Inc. is the larger business by last-quarter revenue ($15.2B vs $14.5B, roughly 1.1× ASTRAZENECA PLC). PDD Holdings Inc. runs the higher net margin — 27.1% vs 16.9%, a 10.2% gap on every dollar of revenue.
AstraZeneca plc (AZ) is a Swedish-British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
Pinduoduo is a Chinese online retailer, with a focus on the traditional agriculture industry. The business is the largest product of PDD Holdings, a company currently headquartered in Ireland that also owns the online marketplace Temu.
AZN vs PDD — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $14.5B | $15.2B |
| Net Profit | $2.4B | $4.1B |
| Gross Margin | 82.9% | 56.7% |
| Operating Margin | 24.3% | 23.1% |
| Net Margin | 16.9% | 27.1% |
| Revenue YoY | 11.7% | — |
| Net Profit YoY | 27.0% | — |
| EPS (diluted) | $1.57 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $15.2B | ||
| Q2 25 | $14.5B | $14.5B | ||
| Q3 24 | — | $14.2B | ||
| Q2 24 | $12.9B | — | ||
| Q1 24 | — | $12.0B | ||
| Q3 23 | — | $9.4B | ||
| Q2 23 | $11.4B | $7.2B | ||
| Q4 22 | — | $5.8B |
| Q3 25 | — | $4.1B | ||
| Q2 25 | $2.4B | $4.3B | ||
| Q3 24 | — | $3.6B | ||
| Q2 24 | $1.9B | — | ||
| Q1 24 | — | $3.9B | ||
| Q3 23 | — | $2.1B | ||
| Q2 23 | $1.8B | $1.8B | ||
| Q4 22 | — | $1.4B |
| Q3 25 | — | 56.7% | ||
| Q2 25 | 82.9% | 55.9% | ||
| Q3 24 | — | 60.0% | ||
| Q2 24 | 83.1% | — | ||
| Q1 24 | — | 62.3% | ||
| Q3 23 | — | 61.0% | ||
| Q2 23 | 82.8% | 64.3% | ||
| Q4 22 | — | 77.6% |
| Q3 25 | — | 23.1% | ||
| Q2 25 | 24.3% | 24.8% | ||
| Q3 24 | — | 24.5% | ||
| Q2 24 | 21.2% | — | ||
| Q1 24 | — | 29.9% | ||
| Q3 23 | — | 24.2% | ||
| Q2 23 | 21.5% | 24.3% | ||
| Q4 22 | — | 22.9% |
| Q3 25 | — | 27.1% | ||
| Q2 25 | 16.9% | 29.6% | ||
| Q3 24 | — | 25.1% | ||
| Q2 24 | 14.9% | — | ||
| Q1 24 | — | 32.3% | ||
| Q3 23 | — | 22.6% | ||
| Q2 23 | 15.9% | 25.1% | ||
| Q4 22 | — | 23.7% |
| Q3 25 | — | — | ||
| Q2 25 | $1.57 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $1.24 | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | $1.17 | — | ||
| Q4 22 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.1B | $13.0B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $44.8B | $55.0B |
| Total Assets | $112.4B | $86.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $13.0B | ||
| Q2 25 | $7.1B | $8.8B | ||
| Q3 24 | — | $9.3B | ||
| Q2 24 | $6.9B | — | ||
| Q1 24 | — | $7.7B | ||
| Q3 23 | — | $7.5B | ||
| Q2 23 | $5.7B | $4.3B | ||
| Q4 22 | — | $21.7B |
| Q3 25 | — | $55.0B | ||
| Q2 25 | $44.8B | $50.5B | ||
| Q3 24 | — | $39.7B | ||
| Q2 24 | $39.6B | — | ||
| Q1 24 | — | $30.3B | ||
| Q3 23 | — | $22.2B | ||
| Q2 23 | $37.4B | $20.0B | ||
| Q4 22 | — | $17.1B |
| Q3 25 | — | $86.2B | ||
| Q2 25 | $112.4B | $79.2B | ||
| Q3 24 | — | $66.5B | ||
| Q2 24 | $104.3B | — | ||
| Q1 24 | — | $52.3B | ||
| Q3 23 | — | $43.1B | ||
| Q2 23 | $96.5B | $37.8B | ||
| Q4 22 | — | $34.4B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $6.4B |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 1.56× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $6.4B | ||
| Q2 25 | — | $3.0B | ||
| Q3 24 | — | $3.9B | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $2.9B | ||
| Q3 23 | — | $4.5B | ||
| Q2 23 | — | $3.2B | ||
| Q4 22 | — | $7.0B |
| Q3 25 | — | 1.56× | ||
| Q2 25 | — | 0.70× | ||
| Q3 24 | — | 1.10× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.75× | ||
| Q3 23 | — | 2.09× | ||
| Q2 23 | — | 1.78× | ||
| Q4 22 | — | 5.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
